•Sequencing Method: Cancer Tissue WES 600X 30G / Normal Tissue RNA-Seq 30M / Cancer Tissue RNA-Seq 30M
•Bioinformatics Analysis: Hardware-accelerated local analysis
•Interpretation Report: Genome Constitution and Tracking Interpretation Report
Scope of Application
1.Cancer patients seeking a more comprehensive view of the entire 20,000-gene constitution beyond standard cancer tests (typically covering around 500 genes) to gain a precise understanding of their genomic constitution. The analysis results can facilitate personalized constitution management, including tailored herbal treatments.
2.Cancer patients without available targeted therapies who wish to gain deeper insights into their genomic constitution for precise constitution management.
Through ultra-deep whole exome sequencing and dual-sample transcriptome or expression profiling, we decode the gene expression of 20,000 genes, analyzing various acquired genetic variations and real-time changes in genome function, reflecting shifts in constitution. By comparing the results of ultra-deep whole exome sequencing and dual transcriptome or expression profiling with key medical genomic databases from the U.S. and Europe, and applying big data analysis, we gain insights into and track real-time changes in an individual’s acquired genetic constitution. This refined analysis allows for precise personalized constitution management, including tailored herbal constitution adjustments.
1.Cancer patients can gain a comprehensive view of all 20,000 gene constitution changes beyond standard cancer tests (typically covering around 500 genes) to achieve a more precise understanding of their genomic constitution. Analysis results can support the introduction of personalized constitution management, including herbal treatments.
2.Cancer patients without available targeted therapies who wish to gain deeper insights into their genomic constitution for precise constitution management.
